Mark W. Lowdell - Publications, H-index & Citations

Mark W. Lowdell

university college london

49H指数

245论文数

7.9K被引数

收录论文 94

发表时间

Rethinking CAR-T Manufacturing Paradigms: Terminology, Operational Considerations, and Economic Trade-Offs 重新思考CAR-T制造范式：术语、运营考量和经济权衡

Cytotherapy

IF3.2

2026-04-12

OAAI

Chase McCann; Jacob Matriccino; Mark Lowdell; Jason Foster; Eytan Abraham; Matthew Hewitt; Ruiz Gerhardt Astigarraga; Robert Lechich; Josephine Lembong

A Bespoke Programmable Interpenetrating Elastomer Network Composite Laryngeal Stent for Expedited Paediatric Laryngotracheal Reconstruction 一种定制化的可编程互穿弹性体网络复合材料喉支架，用于加速儿童喉气管重建

ADVANCED FUNCTIONAL MATERIALS

IF19

2025-11-01

OAAI

Maughan, Elizabeth F.; Wu, Lei; Zhang, Dong; Wu, Linxiao; Mendes, Graca Ferreira Vaz Pinto; Tu, Wanqiao J.; Ma, Heping; Proctor, Toby J.; Butler, Colin R.; Kjaergaard, Thomas; Lowdell, Mark W.; Birchall, Martin A.; Hynds, Robert E.; Hewitt, Richard; Song, Wenhui

Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines 扩增的适应性NKG2C+ NK细胞对HBV感染的肝癌细胞系表现出强大的ADCC和功能反应。

Cytotherapy

IF3.2

2025-10-25

OAAI

Jonida Kokiçi; Helena Arellano-Ballestero; Benjamin Hammond; Anucha Preechanukul; Noshin Hussain; Kelly da Costa; Jessica Davies; Sadiyah Mukhtar; Thomas Fernandez; Sabine Kinloch; Fiona M Burns; Patrick Kennedy; Douglas MacDonald; Mala K Maini; Upkar S Gill; Alan Xiaodong Zhuang; Mark W Lowdell; Karl-Johan Malmberg; Ebba Sohlberg; Dimitra Peppa

Matched donor allogeneic CAR-T for adult B-ALL: toxicity, efficacy, repeat dosing, and the importance of lymphodepletion 匹配供者异基因CAR-T治疗成人B-ALL：毒性、疗效、重复给药及淋巴细胞清除的重要性

Blood

IF23.1

2025-07-14

PREAI

Claire Roddie; Juliana Dias; Maeve A. O’Reilly; Mahnaz Abbasian; Amaia Cadinanos-Garai; Ketki Vispute; Leticia Bosshard-Carter; Marina Mitsikakou; Eftychia Charalambous; Vedika Mehra; Harriet Roddy; Gordon Weng-Kit Cheung; John A. Hartley; Nasir Mahmoud; Leah Ensell; Yashma Patel; Maria A. V. Marzolini; Farzin Farzaneh; Lauren Nickolay; Nourredine Himoudi; Farhatullah Syed; Bilyana Popova; Sevasti Galani; Alexander Day; Mark W. Lowdell; Karl S. Peggs

Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases 定义间充质基质细胞治疗自身免疫性疾病临床试验同行评审报告的最小标准

Cytotherapy

IF3.2

2025-07-12

OAAI

Lindsay C. Davies; Lucie Biard; Damián García-Olmo; Gary Gilkeson; Massimiliano Gnecchi; Joanne Kurtzberg; Gesine Kogler; Katarina Le Blanc; Mark W. Lowdell; Yves-Marie Pers; Ling-yun Sun; Karin Tarte; Antonio Uccelli; Fermin Sanchez-Guijo; Dominique Farge

Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy

SCIENTIFIC REPORTS

IF3.9

2024-05-19

OAAI

Goldberg, Andrew J.; Masci, Lorenzo; O'Donnell, Paul; Green, Ruth; Brooking, Deirdre; Bassett, Paul; Lowdell, Mark W.; Smith, Roger K. W.

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD

CELL STEM CELL

IF20.4

2023-10-01

OAAI

Kirkeby, Agnete; Nelander, Jenny; Hoban, Deirdre B.; Rogelius, Nina; Bjartmarz, Hjalmar; Storm, Petter; Fiorenzano, Alessandro; Adler, Andrew F.; Vale, Shelby; Mudannayake, Janitha; Zhang, Yu; Cardoso, Tiago; Mattsson, Bengt; Landau, Anne M.; Glud, Andreas N.; Sorensen, Jens C.; Lillethorup, Thea P.; Lowdell, Mark; Carvalho, Carla; Bain, Owen; van Vliet, Trinette; Lindvall, Olle; Bjorklund, Anders; Harry, Bronwen; Cutting, Emma; Widner, Hakan; Paul, Gesine; Barker, Roger A.; Parmar, Malin

Bringing function to the forefront of cell therapy: how do we demonstrate potency?

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-07-11

OAAI

Lowdell, Mark W. W.; Weil, Ben

Human platelet lysate enhances proliferation but not chondrogenic differentiation of pediatric mesenchymal progenitors

CYTOTHERAPY

IF3.2

2023-03-01

OAAI

Gardner, Oliver F. W.; Agabalyan, Natacha; Weil, Ben; Ali, Mohammed H. I.; Lowdell, Mark W.; Bulstrode, Neil W.; Ferretti, Patrizia

A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome

CELLS

IF5.2

2023-02-16

OAAI

Arellano-Ballestero, Helena; Sabry, May; Lowdell, Mark W.

Validation of the Achilles VELOS process 2 manufacturing platform for the treatment of solid cancer: GMP scale runs generate a significant dose boost of highly potent clonal neoantigen reactive T-cells

ANNALS OF ONCOLOGY

IF65.4

2021-12-01

OAAI

Samuel, E. R.; Rologi, E.; Fraser, H.; Sassi, M.; Pruchniak, M.; Kotsiou, E.; Robinson, J.; Benzekhroufa, K.; Goodsell, L.; Carolan, C.; Saggese, M.; Grant, M.; Samways, B.; Kotecha, P.; Schmitt, A.; Lawrence, D.; Forster, M.; Turajlic, S.; Lowdell, M.; Quezada, S.

GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering

SCIENTIFIC REPORTS

IF3.9

2021-06-11

OAAI

Tait, Angela; Proctor, Toby; Hamilton, Nick J. I.; Birchall, Martin A.; Lowdell, Mark W.

Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia

CYTOTHERAPY

IF3.2

2021-06-01

OAAI

Robertson, Nicola J.; Meehan, Christopher; Martinello, Kathryn A.; Avdic-Belltheus, Adnan; Boggini, Tiziana; Mutshiya, Tatenda; Lingam, Ingran; Yang, Qin; Sokolska, Magdalena; Charalambous, Xenia; Bainbridge, Alan; Hristova, Mariya; Kramer, Boris W.; Golay, Xavier; Weil, Ben; Lowdell, Mark W.

The development of a personalized autologous clonal neoantigen T cell therapy for the treatment of solid cancer using the VELOS™ manufacturing platform generates highly potent and reactive CD8+and CD4+T cells for clinical use

CANCER RESEARCH

IF16.6

2020-08-15

PREAI

Fraser, Henrieta; Pike, Rebecca; Thirkell, Sarah; Arshad, Asiya; Jide-Banwo, Sam; Bartley, Hollie; Rologi, Evi; Pruchniak, Michal; Patel, Shreenal; Mootien, Jennine; Robertson, Jane; Craig, Andrew; Salm, Max; Newton, Katy; Goodsell, Luke; Chan, Fong; Wilson, Gareth; Frenk, Stephen; Ali, Iraj; Peggs, Karl; Lowdell, Mark W.; Del Rosio, Lyra; Hayes, Andrew; Turajlic, Samra; Islam, Farah; Lawrence, David; Jamal-Hanjani, Mariam; Forster, Martin D.; Samuel, Edward

Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with 89Zr-oxine PET-CT

STEM CELL RESEARCH & THERAPY

IF7.3

2020-06-26

OAAI

Patrick, P. Stephen; Kolluri, Krishna K.; Zaw Thin, May; Edwards, Adam; Sage, Elizabeth K.; Sanderson, Tom; Weil, Benjamin D.; Dickson, John C.; Lythgoe, Mark F.; Lowdell, Mark; Janes, Sam M.; Kalber, Tammy L.

Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer

STEM CELLS TRANSLATIONAL MEDICINE

IF4.9

2020-05-16

OAAI

Sabry, May; Lowdell, Mark W.

Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function

HAEMATOLOGICA

IF7.9

2019-11-21

OAAI

Cuadrado, Maria M.; Szydlo, Richard M.; Watts, Mike; Patel, Nishil; Renshaw, Hanna; Dorman, Jude; Lowdell, Mark; Ings, Stuart; Anthias, Chloe; Madrigal, Alejandro; Mackinnon, Stephen; Kottaridis, Panagiotis; Carpenter, Ben; Hough, Rachael; Morris, Emma; Thomson, Kirsty; Peggs, Karl S.; Chakraverty, Ronjon

Umbilical cord-derived mesenchymal stromal cells in cardiovascular disease: review of preclinical and clinical data

CYTOTHERAPY

IF3.2

2019-10-01

PREAI

Colicchia, Martina; Jones, Daniel A.; Beirne, Anne-Marie; Hussain, Mohsin; Weeraman, Deshan; Rathod, Krishnaraj; Veerapen, Jessry; Lowdell, Mark; Mathur, Anthony

Adipose-Derived Stem Cells for Regenerative Wound Healing Applications: Understanding the Clinical and Regulatory Environment

AESTHETIC SURGERY JOURNAL

IF3.9

2019-08-13

OAAI

Luck, Joshua; Weil, Benjamin D.; Lowdell, Mark; Mosahebi, Afshin

T-cell receptor gene-modified cells: past promises, present methodologies and future challenges

CYTOTHERAPY

IF3.2

2019-03-01

OAAI

Rego, Rita Tendeiro; Morris, Emma C.; Lowdell, Mark W.

研究方向